$38.48 +0.06 (%) Abbott Laboratories - New York Stock Exchange, Inc.

Dec. 7, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Dividend Income Update November 2016

    TalkMarkets | Dec. 4, 2016 | 21:02PM EST
  2. Dividend Aristocrats In Focus Part 29: Abbott Laboratories

    TalkMarkets | Nov. 3, 2016 | 11:54AM EST
  3. Dividend Aristocrats In Focus Part 28: Abbvie

    TalkMarkets | Nov. 3, 2016 | 10:25AM EST
  4. Morgan Stanley Beats Estimates, Abbott Laboratories Just Ahead

    TalkMarkets | Oct. 19, 2016 | 09:31AM EST
  5. The Market Glance For October 17th: Will IBM Sing the Blues?

    Dividend.com | Oct. 17, 2016 | 09:00AM EST
  6. Stocks Going Ex Dividend The Second Week Of October

    TalkMarkets | Oct. 9, 2016 | 18:47PM EST
  7. J&J Finally Returning to Its Roots in Diversity?

    GuruFocus | Sep. 26, 2016 | 11:04AM EST
  8. Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO

    TalkMarkets | Sep. 23, 2016 | 12:15PM EST
  9. Don’t Worry, AbbVie Will Be Just Fine

    Dividend.com | Aug. 31, 2016 | 08:00AM EST
  10. Mylan Will Buy Meda For $9.9 Billion, Q4 Earnings Miss; Stock Dives

    IBD | Feb. 10, 2016 | 17:30PM EST
  11. Valeant's Share Price Continues to Decline

    GuruFocus | Feb. 5, 2016 | 15:10PM EST
  12. Benzinga's M&A Chatter for Monday February 1, 2015

    Benzinga | Feb. 1, 2016 | 19:53PM EST
  13. Mid-Afternoon Market Update: Roper Technologies Falls Following Weak Results; Questar Shares Spike Higher

    Benzinga | Feb. 1, 2016 | 14:37PM EST
  14. Mid-Day Market Update: Crude Oil Drops Over 4%; Alere Shares Gain On Acquisition News

    Benzinga | Feb. 1, 2016 | 12:23PM EST
  15. Benzinga's Volume Movers

    Benzinga | Feb. 1, 2016 | 10:26AM EST
  16. Mid-Morning Market Update: Markets Open Lower; Abbott Laboratories To Buy Alere For $56/Share

    Benzinga | Feb. 1, 2016 | 10:11AM EST
  17. Benzinga's Top Downgrades

    Benzinga | Jan. 29, 2016 | 09:25AM EST
  18. Earnings Recap For January 28

    Benzinga | Jan. 28, 2016 | 16:34PM EST
  19. Mid-Day Market Update: Facebook Surges On Strong Results; ServiceNow Shares Slip

    Benzinga | Jan. 28, 2016 | 12:00PM EST
  20. Earnings Scheduled For January 28, 2016

    Benzinga | Jan. 28, 2016 | 04:04AM EST
  21. Experienced Insider Continues to Buy Absolute Software

    GuruFocus | Jan. 24, 2016 | 18:18PM EST
  22. Expect Conservative Guidance For Medical Tech Stocks?

    Benzinga | Jan. 22, 2016 | 11:11AM EST
  23. Gilead, Other Biotechs Selling Off On Market Weakness

    Benzinga | Jan. 4, 2016 | 14:22PM EST
  24. Benzinga's Top Downgrades

    Benzinga | Jan. 4, 2016 | 09:32AM EST
  25. US Stock Futures Signal Lower Start On Wall Street

    Benzinga | Jan. 4, 2016 | 07:32AM EST
  26. Barron's Recap: The Outlook For 2016

    Benzinga | Dec. 13, 2015 | 16:12PM EST
  27. Abbott a Dividend Aristocrat Stock Propelled by Emerging Markets

    GuruFocus | Dec. 11, 2015 | 18:34PM EST
  28. Hologic Upgraded On 'Multi-Year Growth' Prediction

    IBD | Dec. 11, 2015 | 12:40PM EST
  29. Jefferies Says It's Buying Abbott Labs Stock On Emerging Market Growth, Valuation

    Benzinga | Dec. 7, 2015 | 10:34AM EST
  30. Benzinga's Top Upgrades

    Benzinga | Dec. 7, 2015 | 08:59AM EST
  31. GoPro PT Cut; Chipotle, Bluebird Bio Downgraded

    IBD | Dec. 7, 2015 | 08:56AM EST
  32. US Stock Futures Edge Higher; Crude Oil Slides

    Benzinga | Dec. 7, 2015 | 06:47AM EST
  33. Time To Buy Mylan's Clear Path To EPS Upside, JP Morgan Says

    Benzinga | Nov. 18, 2015 | 10:22AM EST
  34. Goldman Is Downgrading Abbott Laboratories

    Benzinga | Nov. 13, 2015 | 09:56AM EST
  35. Benzinga's Top Downgrades

    Benzinga | Nov. 13, 2015 | 08:39AM EST
  36. Boston Scientific Pops As Growth Beats FX Headwinds

    IBD | Oct. 28, 2015 | 12:37PM EST
  37. 10 Stocks To Watch For October 21, 2015

    Benzinga | Oct. 21, 2015 | 03:58AM EST
  38. Earnings Scheduled For October 21, 2015

    Benzinga | Oct. 21, 2015 | 03:09AM EST
  39. McDonald's Mulls Real Estate Move Amid REIT Calls

    IBD | Oct. 15, 2015 | 17:02PM EST
  40. Benzinga's Top Upgrades

    Benzinga | Oct. 7, 2015 | 08:37AM EST
  41. Barclays Upgrades Abbott, Sees 'Selling Overdone'

    Benzinga | Oct. 7, 2015 | 07:28AM EST
  42. Benzinga's M&A Chatter for Thursday August 27, 2015

    Benzinga | Aug. 27, 2015 | 18:15PM EST
  43. Benzinga's Volume Movers

    Benzinga | Aug. 27, 2015 | 09:49AM EST
  44. Morning Market Gainers

    Benzinga | Aug. 27, 2015 | 08:43AM EST
  45. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 27, 2015 | 07:12AM EST
  46. The Coming Drug-Patent Cliff Is Pushing This Portfolio Up

    Benzinga | Aug. 20, 2015 | 13:48PM EST
  47. Baxalta Vs. AbbVie: Biopharma Spin-Off Battle

    GuruFocus | Aug. 20, 2015 | 11:01AM EST
  48. Probes Reporter Provides Updates On Six SEC Investigations

    Benzinga | Aug. 12, 2015 | 13:58PM EST
  49. Profit from Emerging Market Health Care Growth With Abbott Laboratories

    GuruFocus | Jul. 25, 2015 | 09:04AM EST
  50. New Cardiac Devices Get Investors' Hearts Pumping

    IBD | Jul. 24, 2015 | 14:16PM EST
Trading Center